drugset / Trial / NCT03325296

Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.

NCT03325296

Phase 2 Terminated 13 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical trial attempts to investigate the efficacy of LEO 124249 ointment in the treatment of alopecia areata on the eyebrows.

Timeline

Start
2017-10-30
Primary completion
2018-05-16
Completion
2018-05-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Delgocitinib Small molecule Topical

Indications